Diagnostics Pipeline: Savara Introduces Blood Test to Detect aPAP, a Rare Lung Disorder
Savara’s ClearPath assay needs just a few drops of blood to test for aPAP, a condition that can be difficult and invasive to diagnose
Emerging Tests-dtet
Image-Based AI Touted as a New Weapon Against Rare Cancers
Studies by Paige demonstrate the greater accuracy that artificial intelligence potentially offers for pathologists
Diagnostics Pipeline: Roche’s New Cobas Liat Panel Can Test for Multiple STIs Simultaneously
The PCR-driven test provides results in about 20 minutes in non-laboratory settings
Methylation Patterns Are New Target for ctDNA Analysis
...
Already a member? Log in here
Disposable, Electrochemical Sensor IDs Wound Infections in Seconds
...
Already a member? Log in here
Inflammatory Markers May Diagnose Back Conditions
...
Already a member? Log in here
NGS-Based Test for CF Promises Faster, Cheaper, More Thorough Analysis
...
Already a member? Log in here
More Than 1/4 of FDA’s 2015 Drug Approvals for Targeted Therapies
From - Diagnostic Testing & Emerging Technologies
More than 28 percent of the novel new drugs approved by U.S. Food and Drug Administration (FDA) in 2015 were…
New Molecular Test for Cystic Fibrosis Promises Faster, Better, Cheaper Analysis
From - Diagnostic Testing & Emerging Technologies
The future of cystic fibrosis (CF) diagnosis is in sight. Testing for the genetic disease helped to fuel the first wave of clinical molecular diagnostics, and now an assay developed by…
Paper-Based Test May Increase Male Fertility Self-Testing
...
Already a member? Log in here
Cost Effectiveness of Nail Fungus Confirmatory Test Treatment-Specific
...
Already a member? Log in here
Rise in Lyme Cases Drives Interest in New Tests
...
Already a member? Log in here